The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Vladimir Tolmachev sits on this spectrum.
This scientist: 448 publications — 93rd percentile
93% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Vladimir Tolmachev sits on this spectrum.
This scientist: 70 D-Index — 65th percentile
65% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Vladimir Tolmachev is affiliated with Uppsala University in Sweden and has a research focus primarily within the field of Medicine, with a substantial emphasis on Radiology, Nuclear Medicine and Imaging. Their work spans several related subfields including Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, and Epidemiology.
The main research topics covered in Tolmachev's publications include:
Tolmachev has contributed numerous articles to multiple scientific journals, with the most frequent publication venues comprising:
Recent papers by Tolmachev illustrate a focus on molecular imaging and targeted therapeutic probes, including:
Other closely associated works often feature collaboration with frequent coauthors such as:
Tolmachev's studies often revolve around imaging techniques, protein-based probes for cancer diagnostics, and molecular targeting strategies. Examples include investigations of DARPin-based probes and scaffold protein-based visualization methods for HER2 expression in breast cancer, contributing to the field of nuclear medicine and radiopharmacy.
The scientific contributions of Tolmachev encompass a range of highly cited research papers that support developments in the intersection of molecular imaging and oncology, reinforcing the role of targeted radiopharmaceuticals in personalized medicine approaches.
John Löfblom;Joachim Feldwisch;Vladimir Tolmachev;Jörgen Carlsson
Anna Orlova;Mikaela Magnusson;Tove L.J. Eriksson;Martin Nilsson
Maria Wikman;Ann-Charlott Steffen;Elin Gunneriusson;Vladimir Tolmachev
Richard P. Baum;Vikas Prasad;Dirk Müller;Christiane Schuchardt
Vladimir Tolmachev;Anna Orlova;Rikard Pehrson;Joakim Galli
Jens Sörensen;Dan Sandberg;Mattias Sandström;Anders Wennborg
Jens Sörensen;Irina Velikyan;Dan Sandberg;Anders Wennborg
Anna Orlova;Vladimir Tolmachev;Rikard Pehrson;Malin Lindborg
Jan Terje Andersen;Rikard Pehrson;Vladimir Tolmachev;Muluneh Bekele Daba
Mohamed Altai;Rosemery Membreno;Brendon Cook;Vladimir Tolmachev
Mikaela Friedman;Anna Orlova;Eva Johansson;Tove L. J. Eriksson
Joachim Feldwisch;Vladimir Tolmachev;Christofer Lendel;Nina Herne
Irina Velikyan;Åsa Liljegren Sundberg;Örjan Lindhe;A Urban Höglund
Vladimir Tolmachev;Anna Orlova;Fredrik Y Nilsson;Joachim Feldwisch
Anna Orlova;Helena Wållberg;Sharon Stone-Elander;Vladimir Tolmachev
Vladimir Tolmachev
Ann-Charlott Steffen;Maria Wikman;Vladimir Tolmachev;Gregory P. Adams
Fredrik Y Nilsson;Vladimir Tolmachev
Xiujuan Li;Narendra Padhan;Elisabet O. Sjöström;Francis P. Roche
Vladimir Tolmachev;Mikaela Friedman;Mattias Sandström;Tove L.J. Eriksson
If you think any of the details on this page are incorrect, let us know.
McMaster University
University of Central Missouri
Johannes Gutenberg University of Mainz
University of Wisconsin–Madison
Harvard-Smithsonian Center for Astrophysics
Rutgers, The State University of New Jersey
National Institutes of Health
Vita-Salute San Raffaele University
Max Planck Society
IrsiCaixa
University of Erlangen-Nuremberg
University of Padua
Indiana University
University of South Florida
University of Bologna
University of Southampton
